Vernon Hills, IL, United States of America

Andrey Ugolkov

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Curis, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrey Ugolkov. Retrieved from https://idiyas.com/inventor/andrey-ugolkov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrey Ugolkov: Innovator in Cancer Treatment

Introduction

Andrey Ugolkov is a notable inventor based in Vernon Hills, IL (US). He has made significant contributions to the field of cancer treatment through his innovative approaches and research.

Latest Patents

Ugolkov holds a patent for "Combination therapies for the treatment of cancer." This patent focuses on methods of treating certain diseases and disorders, particularly cancer, using a combination of an IRAK4 inhibitor, a BCL-2 inhibitor, and a nucleoside analog. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Andrey Ugolkov is associated with Curis, Inc., a company dedicated to developing innovative cancer therapies. His work at Curis has positioned him as a key player in the fight against cancer, contributing to the development of effective treatment options.

Collaborations

Ugolkov has collaborated with esteemed colleagues such as Reinhard Von Roemeling and Robert Martell. These partnerships have enhanced his research and broadened the impact of his work in the medical community.

Conclusion

Andrey Ugolkov's contributions to cancer treatment through his innovative patent and collaborations highlight his dedication to improving patient outcomes. His work continues to inspire advancements in the field of oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…